Severe ocular irritation and corneal deposits associated with capecitabine use.
Waikhom
B
B
Fraunfelder
F T
FT
Henner
W D
WD
Walkhom
B
B
D000970:Antineoplastic Agents / Q000009:adverse effects*; D001943:Breast Neoplasms / Q000556:secondary; D000069287:Capecitabine; D003316:Corneal Diseases / Q000139:chemically induced*; D003841:Deoxycytidine / Q000009:adverse effects* / Q000031:analogs & derivatives*; D005260:Female; D005472:Fluorouracil / Q000031:analogs & derivatives; D006801:Humans; D007634:Keratitis / Q000139:chemically induced; D007638:Keratoconjunctivitis Sicca / Q000150:complications; D008875:Middle Aged; D014792:Visual Acuity / Q000187:drug effects*
D000970:Antineoplastic Agents; D003841:Deoxycytidine; D000069287:Capecitabine; D005472:Fluorouracil